First-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that causes muscle weakness, an enlarged heart, and shortened life…
Medical researchers at Johns Hopkins aim to accelerate therapies that improve and save lives as liver cancer becomes one of the most common cancers in…
Experts at Johns Hopkins and across the country work together to better understand the behavior and characteristics of respiratory viruses, how our immune system responds…
Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children’s Hospital and four other institutions have devised a novel method to test for prostate cancer using…
The ICTR is proud to welcome the newest cohort of the Johns Hopkins Clinical Research Scholars (JHCRS) Program (K12, formerly KL2). These talented scholars join…
Johns Hopkins, the NIH, and others partnered to develop a test with more than 98% accuracy, opening new avenues for early diagnosis, improved patient care,…
A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers using…
The Johns Hopkins Institute for Clinical and Translational Research (ICTR) is excited to invite you to a new, advanced-level course. Advanced Topics in Clinical Research,…
The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment The early signs of Alzheimer’s disease—more frequent…
2025 ICTR Team Science Workshop Building Psychological Safety: Identifying and Addressing Common Barriers Monday, September 8, 2025 | 1-2:00 pm Learn how to identify &…